<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="description" content="A comprehensive guide to understanding mirtazapine - its mechanism of action, therapeutic uses, side effects, and what makes this NaSSA antidepressant unique.">
    <title>Understanding Mirtazapine: A Complete Guide | Tune Health</title>

    <!-- Preconnect for performance -->
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>

    <!-- Editorial Typography -->
    <link href="https://fonts.googleapis.com/css2?family=Playfair+Display:ital,wght@0,400;0,500;0,600;0,700;0,800;1,400;1,500;1,600&family=Inter:wght@300;400;500;600;700&family=Crimson+Pro:ital,wght@0,300;0,400;0,500;0,600;1,300;1,400;1,500&display=swap" rel="stylesheet">

    <!-- Styles -->
    <link rel="stylesheet" href="/css/style.css">

    <!-- Favicon -->
    <link rel="icon" type="image/svg+xml" href="/assets/favicon.svg">

    <!-- Open Graph -->
    <meta property="og:title" content="Understanding Mirtazapine: A Complete Guide">
    <meta property="og:description" content="An in-depth exploration of mirtazapine's mechanism of action, therapeutic applications, and what makes this medication distinct.">
    <meta property="og:type" content="article">
    <meta property="og:site_name" content="Tune Health">
</head>
<body class="overflow-x-hidden">
    <!-- Noise Overlay -->
    <div class="noise-overlay"></div>

    <!-- Scroll Progress -->
    <div class="scroll-progress" id="scrollProgress"></div>

    <!-- Navigation -->
    <header class="nav-header" id="header">
        <nav class="nav-inner">
            <!-- Left Nav -->
            <div class="flex items-center gap-6">
                <a href="/" class="flex items-center gap-2 text-sm font-medium text-stone-600 dark:text-stone-400 hover:text-stone-900 dark:hover:text-white transition-colors">
                    <svg class="w-5 h-5" fill="none" stroke="currentColor" viewBox="0 0 24 24">
                        <path d="M19 12H5M12 19l-7-7 7-7" stroke-width="2"/>
                    </svg>
                    <span class="hidden sm:inline">Back to Home</span>
                </a>
            </div>

            <!-- Logo -->
            <a href="/" class="flex items-baseline gap-1 font-serif text-xl md:text-2xl font-semibold group">
                <span class="text-primary-600 font-bold text-2xl md:text-3xl transition-transform duration-300 group-hover:scale-110">T</span>
                <span class="text-stone-900 dark:text-white">une</span>
                <em class="font-normal text-stone-600 dark:text-stone-400">Health</em>
            </a>

            <!-- Right Nav -->
            <div class="flex items-center gap-4">
                <!-- Share Button -->
                <button class="w-10 h-10 rounded-full flex items-center justify-center hover:bg-stone-100 dark:hover:bg-stone-800 transition-colors" id="shareBtn" aria-label="Share">
                    <svg class="w-5 h-5 text-stone-600 dark:text-stone-400" fill="none" stroke="currentColor" viewBox="0 0 24 24">
                        <path d="M4 12v8a2 2 0 002 2h12a2 2 0 002-2v-8M16 6l-4-4-4 4M12 2v13" stroke-width="2"/>
                    </svg>
                </button>

                <!-- Theme Toggle -->
                <button class="w-10 h-10 rounded-full flex items-center justify-center hover:bg-stone-100 dark:hover:bg-stone-800 transition-colors" id="themeToggle" aria-label="Toggle theme">
                    <svg class="w-5 h-5 text-stone-600 dark:text-stone-400 dark:hidden" fill="none" stroke="currentColor" viewBox="0 0 24 24">
                        <circle cx="12" cy="12" r="5" stroke-width="2"/>
                        <path d="M12 1v2M12 21v2M4.22 4.22l1.42 1.42M18.36 18.36l1.42 1.42M1 12h2M21 12h2M4.22 19.78l1.42-1.42M18.36 5.64l1.42-1.42" stroke-width="2"/>
                    </svg>
                    <svg class="w-5 h-5 text-stone-400 hidden dark:block" fill="none" stroke="currentColor" viewBox="0 0 24 24">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z" stroke-width="2"/>
                    </svg>
                </button>
            </div>
        </nav>
    </header>

    <!-- Article Hero -->
    <section class="article-hero bg-stone-50 dark:bg-stone-950">
        <div class="container-editorial">
            <div class="article-header">
                <!-- Meta -->
                <div class="flex items-center justify-center gap-3 mb-6">
                    <span class="px-3 py-1 bg-primary-100 dark:bg-primary-900/30 text-primary-600 dark:text-primary-400 text-xs font-semibold uppercase tracking-wide rounded-full">Mental Health</span>
                    <span class="text-sm text-stone-500">December 10, 2024</span>
                    <span class="text-stone-400">·</span>
                    <span class="text-sm text-stone-500">12 min read</span>
                </div>

                <!-- Title -->
                <h1 class="font-serif text-display-2 font-semibold mb-6 text-balance">
                    Understanding Mirtazapine: A Complete Guide to This Unique Antidepressant
                </h1>

                <!-- Excerpt -->
                <p class="font-body text-body-lg text-stone-600 dark:text-stone-400 max-w-2xl mx-auto mb-8">
                    An in-depth exploration of mirtazapine's mechanism of action, therapeutic applications,
                    and what makes this medication distinct in the landscape of modern antidepressants.
                </p>

                <!-- Author -->
                <div class="flex items-center justify-center gap-4">
                    <div class="w-12 h-12 rounded-full bg-primary-600 flex items-center justify-center text-white font-semibold">TH</div>
                    <div class="text-left">
                        <span class="block text-sm font-semibold">Tune Health Editorial</span>
                        <span class="block text-xs text-stone-500">Medical Review Board</span>
                    </div>
                </div>
            </div>
        </div>
    </section>

    <!-- Feature Image -->
    <div class="container-editorial">
        <div class="article-feature-image reveal">
            <svg viewBox="0 0 1200 600" class="w-full h-full">
                <defs>
                    <linearGradient id="articleGrad1" x1="0%" y1="0%" x2="100%" y2="100%">
                        <stop offset="0%" style="stop-color:#1a1a2e"/>
                        <stop offset="100%" style="stop-color:#16213e"/>
                    </linearGradient>
                    <linearGradient id="articleGrad2" x1="0%" y1="0%" x2="100%" y2="0%">
                        <stop offset="0%" style="stop-color:#dc2626"/>
                        <stop offset="100%" style="stop-color:#ef4444"/>
                    </linearGradient>
                    <filter id="glow">
                        <feGaussianBlur stdDeviation="3" result="coloredBlur"/>
                        <feMerge>
                            <feMergeNode in="coloredBlur"/>
                            <feMergeNode in="SourceGraphic"/>
                        </feMerge>
                    </filter>
                </defs>
                <rect width="1200" height="600" fill="url(#articleGrad1)"/>

                <!-- Neural network visualization -->
                <g opacity="0.6" filter="url(#glow)">
                    <!-- Neurons -->
                    <circle cx="200" cy="200" r="8" fill="#dc2626"/>
                    <circle cx="350" cy="150" r="8" fill="#dc2626"/>
                    <circle cx="300" cy="300" r="8" fill="#dc2626"/>
                    <circle cx="450" cy="250" r="8" fill="#dc2626"/>
                    <circle cx="500" cy="350" r="8" fill="#dc2626"/>
                    <circle cx="600" cy="200" r="10" fill="#ef4444"/>
                    <circle cx="650" cy="320" r="8" fill="#dc2626"/>
                    <circle cx="750" cy="150" r="8" fill="#dc2626"/>
                    <circle cx="800" cy="280" r="8" fill="#dc2626"/>
                    <circle cx="900" cy="200" r="8" fill="#dc2626"/>
                    <circle cx="950" cy="350" r="8" fill="#dc2626"/>
                    <circle cx="1000" cy="250" r="8" fill="#dc2626"/>

                    <!-- Connections -->
                    <path d="M200 200 Q275 175 350 150" stroke="#dc2626" stroke-width="1" fill="none" opacity="0.5"/>
                    <path d="M200 200 Q250 250 300 300" stroke="#dc2626" stroke-width="1" fill="none" opacity="0.5"/>
                    <path d="M350 150 Q400 200 450 250" stroke="#dc2626" stroke-width="1" fill="none" opacity="0.5"/>
                    <path d="M300 300 Q375 275 450 250" stroke="#dc2626" stroke-width="1" fill="none" opacity="0.5"/>
                    <path d="M450 250 Q475 300 500 350" stroke="#dc2626" stroke-width="1" fill="none" opacity="0.5"/>
                    <path d="M450 250 Q525 225 600 200" stroke="#ef4444" stroke-width="2" fill="none" opacity="0.7"/>
                    <path d="M500 350 Q575 335 650 320" stroke="#dc2626" stroke-width="1" fill="none" opacity="0.5"/>
                    <path d="M600 200 Q675 260 650 320" stroke="#ef4444" stroke-width="2" fill="none" opacity="0.7"/>
                    <path d="M600 200 Q675 175 750 150" stroke="#ef4444" stroke-width="2" fill="none" opacity="0.7"/>
                    <path d="M650 320 Q725 300 800 280" stroke="#dc2626" stroke-width="1" fill="none" opacity="0.5"/>
                    <path d="M750 150 Q825 215 800 280" stroke="#dc2626" stroke-width="1" fill="none" opacity="0.5"/>
                    <path d="M800 280 Q850 240 900 200" stroke="#dc2626" stroke-width="1" fill="none" opacity="0.5"/>
                    <path d="M800 280 Q875 315 950 350" stroke="#dc2626" stroke-width="1" fill="none" opacity="0.5"/>
                    <path d="M900 200 Q950 225 1000 250" stroke="#dc2626" stroke-width="1" fill="none" opacity="0.5"/>
                    <path d="M950 350 Q975 300 1000 250" stroke="#dc2626" stroke-width="1" fill="none" opacity="0.5"/>
                </g>

                <!-- Decorative circles -->
                <circle cx="600" cy="300" r="200" fill="none" stroke="url(#articleGrad2)" stroke-width="1" opacity="0.2"/>
                <circle cx="600" cy="300" r="250" fill="none" stroke="#fff" stroke-width="0.5" opacity="0.1"/>
                <circle cx="600" cy="300" r="150" fill="none" stroke="#fff" stroke-width="0.5" opacity="0.1"/>

                <!-- Central glow -->
                <circle cx="600" cy="300" r="100" fill="url(#articleGrad2)" opacity="0.15"/>

                <!-- Bottom wave -->
                <path d="M0 550 Q300 500 600 530 T1200 510 V600 H0 Z" fill="#0c0a09" opacity="0.3"/>
            </svg>
        </div>
    </div>

    <!-- Article Content -->
    <article class="article-body">
        <div class="container-editorial">
            <div class="max-w-article mx-auto">
                <!-- Table of Contents -->
                <div class="mb-12 p-6 bg-stone-100 dark:bg-stone-900 rounded-2xl reveal">
                    <h2 class="font-serif text-lg font-semibold mb-4">In This Article</h2>
                    <nav class="space-y-2">
                        <a href="#introduction" class="block text-sm text-stone-600 dark:text-stone-400 hover:text-primary-600 transition-colors">Introduction</a>
                        <a href="#mechanism" class="block text-sm text-stone-600 dark:text-stone-400 hover:text-primary-600 transition-colors">Mechanism of Action</a>
                        <a href="#therapeutic" class="block text-sm text-stone-600 dark:text-stone-400 hover:text-primary-600 transition-colors">Therapeutic Uses</a>
                        <a href="#side-effects" class="block text-sm text-stone-600 dark:text-stone-400 hover:text-primary-600 transition-colors">Side Effects</a>
                        <a href="#considerations" class="block text-sm text-stone-600 dark:text-stone-400 hover:text-primary-600 transition-colors">Practical Considerations</a>
                        <a href="#conclusion" class="block text-sm text-stone-600 dark:text-stone-400 hover:text-primary-600 transition-colors">Conclusion</a>
                    </nav>
                </div>

                <!-- Article Prose -->
                <div class="article-content">
                    <section id="introduction" class="reveal">
                        <p>Mirtazapine is a distinctive antidepressant that occupies a unique position in psychiatric pharmacology. Unlike the more commonly prescribed selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs), mirtazapine belongs to a class known as noradrenergic and specific serotonergic antidepressants (NaSSAs). This classification reflects its novel mechanism of action, which sets it apart from other medications used to treat depression and related conditions.</p>

                        <p>First introduced in the Netherlands in 1994 and subsequently approved by the FDA in 1996, mirtazapine has established itself as a valuable option in the psychiatric medication arsenal. Its unique pharmacological profile makes it particularly useful in specific clinical scenarios where other antidepressants may be less suitable or effective.</p>
                    </section>

                    <section id="mechanism" class="reveal">
                        <h2>Mechanism of Action</h2>

                        <p>Understanding how mirtazapine works requires examining its effects on multiple neurotransmitter systems. The medication's mechanism of action is notably different from SSRIs and other common antidepressants.</p>

                        <h3>Alpha-2 Adrenergic Antagonism</h3>

                        <p>Mirtazapine's primary mechanism involves blocking alpha-2 adrenergic receptors. These receptors normally act as "brakes" on the release of norepinephrine and serotonin. By blocking these receptors, mirtazapine effectively releases these brakes, allowing for increased release of both neurotransmitters. This dual enhancement of noradrenergic and serotonergic transmission contributes to its antidepressant effects.</p>

                        <h3>Serotonin Receptor Selectivity</h3>

                        <p>What makes mirtazapine particularly interesting is its selective interaction with serotonin receptors. While it enhances overall serotonergic transmission, it specifically blocks certain serotonin receptor subtypes:</p>

                        <ul>
                            <li><strong>5-HT2 receptors:</strong> Blocking these receptors may contribute to anxiolytic effects and reduced sexual dysfunction compared to SSRIs</li>
                            <li><strong>5-HT3 receptors:</strong> Antagonism at these receptors helps explain why mirtazapine typically causes less nausea than SSRIs and may even have anti-nausea properties</li>
                        </ul>

                        <p>This selective serotonergic action means that while serotonin activity is enhanced through 5-HT1A receptors (associated with antidepressant and anxiolytic effects), the side effects typically mediated by 5-HT2 and 5-HT3 receptors are minimized.</p>
                    </section>

                    <!-- Pull Quote -->
                    <aside class="pull-quote reveal">
                        <p>"Mirtazapine's unique receptor profile makes it particularly valuable for patients who haven't responded well to or can't tolerate other antidepressants."</p>
                    </aside>

                    <section id="therapeutic" class="reveal">
                        <h2>Therapeutic Uses</h2>

                        <h3>Primary Indications</h3>

                        <p><strong>Major Depressive Disorder</strong> remains the primary FDA-approved indication for mirtazapine. Clinical trials have demonstrated its efficacy comparable to other established antidepressants. Some research suggests it may have a faster onset of action than SSRIs, with improvements potentially noticeable within the first one to two weeks of treatment.</p>

                        <h3>Off-Label Applications</h3>

                        <p>Beyond depression, mirtazapine is frequently used off-label for various conditions:</p>

                        <ul>
                            <li><strong>Insomnia:</strong> Its sedating properties make it useful for patients with depression accompanied by significant sleep disturbance</li>
                            <li><strong>Anxiety disorders:</strong> Particularly generalized anxiety disorder and social anxiety</li>
                            <li><strong>Post-traumatic stress disorder (PTSD):</strong> Especially for associated nightmares and sleep disturbances</li>
                            <li><strong>Appetite stimulation:</strong> Useful in patients with cancer, HIV/AIDS, or eating disorders where weight gain is desired</li>
                            <li><strong>Nausea and vomiting:</strong> Due to its 5-HT3 antagonism</li>
                        </ul>
                    </section>

                    <!-- Info Card -->
                    <div class="info-card my-12 reveal">
                        <h4 class="font-serif text-lg font-semibold mb-3 text-primary-700 dark:text-primary-400">Key Dosing Information</h4>
                        <ul class="space-y-2 text-sm">
                            <li><strong>Starting dose:</strong> Typically 15mg taken at bedtime</li>
                            <li><strong>Therapeutic range:</strong> 15-45mg daily</li>
                            <li><strong>Maximum dose:</strong> 45mg per day</li>
                            <li><strong>Note:</strong> Lower doses (15mg) tend to be more sedating than higher doses due to receptor binding patterns</li>
                        </ul>
                    </div>

                    <section id="side-effects" class="reveal">
                        <h2>Side Effects and Considerations</h2>

                        <h3>Common Side Effects</h3>

                        <p>The most frequently reported side effects of mirtazapine reflect its pharmacological profile:</p>

                        <ul>
                            <li><strong>Sedation and drowsiness:</strong> Often most pronounced during initial treatment and at lower doses</li>
                            <li><strong>Increased appetite and weight gain:</strong> Due to histamine H1 receptor blockade</li>
                            <li><strong>Dry mouth:</strong> Related to its anticholinergic properties</li>
                            <li><strong>Constipation:</strong> Also linked to anticholinergic effects</li>
                            <li><strong>Dizziness:</strong> Particularly when standing quickly</li>
                        </ul>

                        <h3>Paradoxical Sedation Pattern</h3>

                        <p>An interesting aspect of mirtazapine is its paradoxical dose-dependent sedation. At lower doses (15mg), sedation is often more pronounced than at higher doses (30-45mg). This occurs because the antihistamine effects predominate at lower doses, while at higher doses, the noradrenergic activation becomes more prominent and counteracts sedation.</p>

                        <h3>Advantages Over Other Antidepressants</h3>

                        <p>Mirtazapine offers several potential advantages compared to SSRIs and SNRIs:</p>

                        <ul>
                            <li><strong>Minimal sexual dysfunction:</strong> Unlike SSRIs, mirtazapine rarely causes sexual side effects</li>
                            <li><strong>Reduced GI side effects:</strong> Less nausea and gastrointestinal disturbance</li>
                            <li><strong>Sleep improvement:</strong> Can be beneficial for patients with insomnia</li>
                            <li><strong>Low drug interaction potential:</strong> Minimal effect on cytochrome P450 enzymes</li>
                        </ul>
                    </section>

                    <section id="considerations" class="reveal">
                        <h2>Practical Considerations</h2>

                        <h3>Who Might Benefit Most</h3>

                        <p>Mirtazapine may be particularly suitable for:</p>

                        <ul>
                            <li>Patients with depression accompanied by significant insomnia</li>
                            <li>Those who have experienced sexual dysfunction with SSRIs</li>
                            <li>Patients with poor appetite or unintended weight loss</li>
                            <li>Elderly patients who may benefit from its sedating and appetite-stimulating properties</li>
                            <li>Those who have not responded adequately to SSRIs or SNRIs</li>
                        </ul>

                        <h3>Populations Requiring Caution</h3>

                        <p>Conversely, mirtazapine may be less suitable for:</p>

                        <ul>
                            <li>Patients concerned about weight gain</li>
                            <li>Those who need to maintain alertness during the day</li>
                            <li>Patients with metabolic syndrome or diabetes (due to potential weight gain)</li>
                            <li>Those with hyperlipidemia (mirtazapine can increase cholesterol levels)</li>
                        </ul>

                        <h3>Discontinuation</h3>

                        <p>While mirtazapine generally has a lower risk of discontinuation syndrome compared to SSRIs, gradual tapering is still recommended when stopping the medication. Abrupt discontinuation can lead to symptoms such as nausea, headache, anxiety, and sleep disturbances.</p>
                    </section>

                    <section id="conclusion" class="reveal">
                        <h2>Conclusion</h2>

                        <p>Mirtazapine represents a valuable and distinct option in the treatment of depression and related conditions. Its unique mechanism of action, involving alpha-2 antagonism and selective serotonin receptor modulation, provides both advantages and specific side effect considerations that differentiate it from other antidepressants.</p>

                        <p>For patients who have struggled with the side effects of SSRIs—particularly sexual dysfunction, insomnia, or nausea—mirtazapine offers an alternative worth considering. Similarly, its appetite-stimulating and sedating properties can be therapeutic benefits in the right clinical context rather than unwanted side effects.</p>

                        <p>As with any medication, the decision to use mirtazapine should be made collaboratively between patient and healthcare provider, weighing individual circumstances, preferences, and the specific clinical presentation. Its place in the antidepressant landscape continues to be valuable precisely because it offers something different from the more commonly prescribed medications.</p>
                    </section>

                    <!-- Disclaimer -->
                    <div class="mt-12 p-6 bg-stone-100 dark:bg-stone-800 rounded-xl border-l-4 border-primary-500 reveal">
                        <p class="text-sm text-stone-600 dark:text-stone-400 leading-relaxed">
                            <strong>Medical Disclaimer:</strong> This article is for informational purposes only and should not be considered medical advice. Always consult with a qualified healthcare provider before starting, stopping, or changing any medication. Individual responses to medications can vary, and only your healthcare provider can determine what is appropriate for your specific situation.
                        </p>
                    </div>
                </div>

                <!-- Share & Tags -->
                <div class="mt-12 pt-8 border-t border-stone-200 dark:border-stone-800 reveal">
                    <div class="flex flex-wrap items-center justify-between gap-6">
                        <div class="flex flex-wrap gap-2">
                            <span class="px-3 py-1 bg-stone-100 dark:bg-stone-800 rounded-full text-sm">Mental Health</span>
                            <span class="px-3 py-1 bg-stone-100 dark:bg-stone-800 rounded-full text-sm">Antidepressants</span>
                            <span class="px-3 py-1 bg-stone-100 dark:bg-stone-800 rounded-full text-sm">Psychiatry</span>
                            <span class="px-3 py-1 bg-stone-100 dark:bg-stone-800 rounded-full text-sm">Medication Guide</span>
                        </div>
                    </div>
                </div>

                <!-- Author Card -->
                <div class="author-card mt-12 reveal">
                    <div class="author-avatar">TH</div>
                    <div>
                        <span class="block font-semibold mb-1">Tune Health Editorial</span>
                        <p class="text-sm text-stone-600 dark:text-stone-400">Our medical review board comprises healthcare professionals dedicated to providing accurate, evidence-based health information. All content is reviewed for accuracy and clinical relevance.</p>
                    </div>
                </div>
            </div>
        </div>
    </article>

    <!-- Related Articles -->
    <section class="related-articles">
        <div class="container-editorial">
            <div class="mb-10">
                <span class="section-label">Continue Reading</span>
                <h2 class="font-serif text-heading-2 font-semibold mt-1">Related Articles</h2>
            </div>

            <div class="grid grid-cols-1 md:grid-cols-3 gap-6">
                <a href="/articles/nicotine-research.html" class="article-card group reveal">
                    <div class="article-card-image">
                        <div class="article-card-image-inner bg-gradient-to-br from-emerald-500 to-teal-600">
                            <span class="article-card-number">01</span>
                        </div>
                    </div>
                    <div class="article-card-content">
                        <div class="flex items-center gap-3 mb-3">
                            <span class="text-xs font-semibold uppercase tracking-wide text-primary-600">Neuroscience</span>
                        </div>
                        <h3 class="font-serif text-xl font-semibold mb-2 group-hover:text-primary-600 transition-colors">Nicotine's Promising Health Benefits</h3>
                        <p class="font-body text-sm text-stone-600 dark:text-stone-400 line-clamp-2">A comprehensive research summary exploring nicotine's therapeutic potential.</p>
                    </div>
                </a>

                <div class="article-card group reveal reveal-delay-1 opacity-75 cursor-default">
                    <div class="article-card-image relative">
                        <div class="article-card-image-inner bg-gradient-to-br from-violet-600 to-purple-700">
                            <span class="article-card-number">02</span>
                        </div>
                        <span class="absolute top-3 right-3 px-2 py-1 bg-stone-900/80 text-white text-xs font-medium rounded">Coming Soon</span>
                    </div>
                    <div class="article-card-content">
                        <div class="flex items-center gap-3 mb-3">
                            <span class="text-xs font-semibold uppercase tracking-wide text-primary-600">Mental Health</span>
                        </div>
                        <h3 class="font-serif text-xl font-semibold mb-2">Understanding Anxiety: A Modern Perspective</h3>
                        <p class="font-body text-sm text-stone-600 dark:text-stone-400 line-clamp-2">The neuroscience behind anxiety and evidence-based treatments.</p>
                    </div>
                </div>

                <div class="article-card group reveal reveal-delay-2 opacity-75 cursor-default">
                    <div class="article-card-image relative">
                        <div class="article-card-image-inner bg-gradient-to-br from-pink-500 to-rose-600">
                            <span class="article-card-number">03</span>
                        </div>
                        <span class="absolute top-3 right-3 px-2 py-1 bg-stone-900/80 text-white text-xs font-medium rounded">Coming Soon</span>
                    </div>
                    <div class="article-card-content">
                        <div class="flex items-center gap-3 mb-3">
                            <span class="text-xs font-semibold uppercase tracking-wide text-primary-600">Sleep Science</span>
                        </div>
                        <h3 class="font-serif text-xl font-semibold mb-2">The Architecture of Deep Sleep</h3>
                        <p class="font-body text-sm text-stone-600 dark:text-stone-400 line-clamp-2">Exploring the stages of sleep and how to optimize each phase.</p>
                    </div>
                </div>
            </div>
        </div>
    </section>

    <!-- Newsletter CTA -->
    <section class="py-20 bg-stone-900 dark:bg-stone-950 text-white">
        <div class="container-editorial text-center">
            <span class="section-label text-primary-400 mb-4 block">Stay Informed</span>
            <h2 class="font-serif text-heading-2 font-semibold mb-4">Get More Health Insights</h2>
            <p class="font-body text-lg text-stone-400 max-w-xl mx-auto mb-8">
                Join our community of readers who receive weekly evidence-based health articles and expert insights.
            </p>
            <form class="flex flex-col sm:flex-row gap-3 max-w-md mx-auto">
                <input type="email" required placeholder="Enter your email"
                       class="flex-1 px-5 py-3.5 bg-stone-800 border border-stone-700 rounded-xl text-base text-white placeholder-stone-500 focus:outline-none focus:border-primary-500 focus:ring-2 focus:ring-primary-500/20 transition-all">
                <button type="submit" class="btn-primary whitespace-nowrap bg-primary-600 hover:bg-primary-500">
                    Subscribe
                </button>
            </form>
        </div>
    </section>

    <!-- Footer -->
    <footer class="footer">
        <div class="container-editorial">
            <div class="flex flex-col md:flex-row justify-between items-center gap-6">
                <a href="/" class="inline-flex items-baseline gap-1 font-serif text-xl font-semibold">
                    <span class="text-primary-600 font-bold text-2xl">T</span>
                    <span>une</span>
                    <em class="font-normal text-stone-500">Health</em>
                </a>
                <p class="text-xs text-stone-400 max-w-md text-center">
                    The content on this site is for informational purposes only and is not a substitute for professional medical advice.
                </p>
                <p class="text-sm text-stone-500">© 2024 Tune Health</p>
            </div>
        </div>
    </footer>

    <!-- Back to Top -->
    <button class="back-to-top" id="backToTop" aria-label="Back to top">
        <svg class="w-6 h-6" fill="none" stroke="currentColor" viewBox="0 0 24 24">
            <path d="M18 15l-6-6-6 6" stroke-width="2"/>
        </svg>
    </button>

    <!-- Scripts -->
    <script type="module" src="/js/main.js"></script>
</body>
</html>